Drugs Controller General of India

Regulatory Nod for Conducting Clinical Trials of Colchicine on COVID-19 Patients: CSIR

NEW DELHI:The Drugs Controller General of India (DCGI) has given approval to the CSIR and Laxai Life Sciences Private Limited…

3 years ago

COVID-19: Zydus Cadila gets DGCI Nod for Phase 3 Clinical Trials with Biological Therapy

NEW DELHI:Drug firm Zydus Cadila on Friday said it has received the approval from the Drugs Controller General of India…

3 years ago

Nod to Serum Institute of India for Phase 2, 3 Human Clinical Trials of Oxford Vaccine Candidate

NEW DELHI: The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for…

4 years ago

This website uses cookies.